JagsonpalPharmaceuticals JAGSNPHARM full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

• Tips
• NEWS
• Tomorrow
• Forecast
• Targets
• ExpertsView
• Analysis
• Munafa AI prediction

• IntraDay predictions, targets, What to do JAGSNPHARM
• Forcast & Targets JAGSNPHARM
• JAGSNPHARM Experts view
• Tomorrow's Movement JAGSNPHARM
• Technical Analysis Reports
• All in One Charts
• All indicators in One Charts
• JAGSNPHARM History
• Money flow charts
• Weekly charts
• Monthly charts
• Moving averages charts
• MACD charts
• Force Index charts
• Stochastics charts
• PVM charts
• RSI and MRSI charts
• Renko charts
• Point and Figure charts

Daily Price and Volume

Weekly Price and Volume

Monthly Price and Volume

Yearly Price and Volume

Indicator Analysis of JagsonpalPharmaceuticals

Tomorrow's movement Prediction of Jagsonpal Pharmaceuticals JAGSNPHARM appears to be in downtrend.

But this trend seems to be weakening.

Price is below an important level of 170.61 on charts, and if price remains below this level, then stock might show a fall in short term.

Tomorrow's movement Prediction of Jagsonpal Pharmaceuticals JAGSNPHARM made a big move recently. This generally happens when there is a positive sentiment change, or a block deal went through. There is a good chance that this trend might continue in coming days.

Munafa value: 45 as on Fri 06 February 2026

This Munafa value indicates that the stock is moving sideways and there is no definite momentum in the stock.

SMA20 is at 172 and price is deviating by 7 points

Upper Bollinger band is at 185 and lower is at 159, while middle bands are at 165 and 178

Price is coming down

Price is below 20day SMA

Price is in upper range of bands

Price action analysis of JagsonpalPharmaceuticals (JAGSNPHARM) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.

ADX buy sell signal for JagsonpalPharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for JagsonpalPharmaceuticals in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

JagsonpalPharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for JagsonpalPharmaceuticals in short term but SELL signal is weak.

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of JagsonpalPharmaceuticals is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 168.41 and JagsonpalPharmaceuticals JAGSNPHARM stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.

People seem to be coming out and selling the JagsonpalPharmaceuticals JAGSNPHARM stock. Volume based technical analysis of JagsonpalPharmaceuticals JAGSNPHARM stock is negative.

JagsonpalPharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

DMA SMA EMA moving averages of Jagsonpal Pharmaceuticals JAGSNPHARM

DMA (daily moving average) of Jagsonpal Pharmaceuticals JAGSNPHARM

DMA period	DMA value
5 day DMA	171.6
12 day DMA	167.73
20 day DMA	171.11
35 day DMA	181.19
50 day DMA	188.87
100 day DMA	204.44
150 day DMA	219.71
200 day DMA	221.12

EMA (exponential moving average) of Jagsonpal Pharmaceuticals JAGSNPHARM

EMA period	EMA current	EMA prev	EMA prev2
5 day EMA	170.2	171.22	171.8
12 day EMA	170.61	171.05	171.23
20 day EMA	173.43	173.98	174.39
35 day EMA	179.99	180.69	181.32
50 day EMA	188.16	188.98	189.75

SMA (simple moving average) of Jagsonpal Pharmaceuticals JAGSNPHARM

SMA period	SMA current	SMA prev	SMA prev2
5 day SMA	171.6	171.78	171.53
12 day SMA	167.73	167.42	167.59
20 day SMA	171.11	172.08	173.15
35 day SMA	181.19	182.12	182.92
50 day SMA	188.87	189.57	190.11
100 day SMA	204.44	205.16	205.94
150 day SMA	219.71	220.12	220.5
200 day SMA	221.12	221.41	221.7

Fundamentals, profit and EPS of Jagsonpal Pharmaceuticals JAGSNPHARM

EPS is 9.32 and PE is: 18.04

Last quarter profit: (September 2025 quarter) 12.57 crores (9.69%)

Debt: 8.84 in crores

Market capitalization: 1337.35

EPS is 9.16 and PE is: 18.36

Last quarter profit: (June 2025 quarter) 10.80 crores (38.64%)

Debt: 9.24 in crores

Market capitalization: 1556.97

Videos related to: JagsonpalPharmaceuticals JAGSNPHARM full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI